Stay updated on LAG-3 in GBM: Alone & with Nivolumab Clinical Trial
Sign up to get notified when there's something new on the LAG-3 in GBM: Alone & with Nivolumab Clinical Trial page.

Latest updates to the LAG-3 in GBM: Alone & with Nivolumab Clinical Trial page
- Check7 days agoChange DetectedThe page's revision tag updated from v3.6.3 to v3.6.4, indicating a minor release or maintenance update. No study content or data appear to be changed.SummaryDifference0.0%

- Check14 days agoChange DetectedPublications section added to the study record. It includes a PubMed-sourced citation for 'Anti-LAG-3 with or without anti-PD-1 in recurrent glioblastoma: a phase 1 trial' and a note that publications are automatically filled from PubMed.SummaryDifference0.2%

- Check21 days agoNo Change Detected
- Check28 days agoChange Detected- The page revision label was updated from v3.6.2 to v3.6.3, indicating a new revision of the page content. This reflects a minor metadata update and does not alter the study details displayed.SummaryDifference0.0%

- Check35 days agoChange DetectedThe page's revision label was updated from v3.6.0 to v3.6.2, signaling a small editorial or formatting update without changing the underlying information.SummaryDifference0.0%

- Check49 days agoChange DetectedThe page now indicates no longer looking for participants and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) along with an updated revision tag to v3.6.0 and a new Intervention/Treatment section. The previously used Intervention / Treatment heading is removed.SummaryDifference0.4%

- Check56 days agoChange DetectedRevision tag updated from v3.5.4 to v3.5.5, indicating a new page version. This change signals an update at the metadata level without altering the study data or visible content.SummaryDifference0.0%

Stay in the know with updates to LAG-3 in GBM: Alone & with Nivolumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LAG-3 in GBM: Alone & with Nivolumab Clinical Trial page.